News Annexon, Inc.

Equities

ANNX

US03589W1027

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
4.7 ^USD	+2.40%		+3.07%	+3.52%

Apr. 01	JPMorgan Raises Price Target on Annexon to $13 From $11, Maintains Overweight Rating	MT
Mar. 27	Wells Fargo Adjusts Price Target on Annexon to $12 From $11, Maintains Overweight Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(4)	Apr. 17	AQ
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)	Apr. 16	GL
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference	Apr. 03	GL
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference	Apr. 03	AQ
JPMorgan Raises Price Target on Annexon to $13 From $11, Maintains Overweight Rating	Apr. 01	MT
Wells Fargo Adjusts Price Target on Annexon to $12 From $11, Maintains Overweight Rating	Mar. 27	MT
Annexon Q4 Loss Narrows	Mar. 26	MT
Annexon, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones	Mar. 26	GL
Annexon, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 26	CI
North American Morning Briefing : Stocks Struggle After New Records	Mar. 22	DJ
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)	Mar. 18	GL
North American Morning Briefing : Inflation Worries Continue to Weigh on Mood	Mar. 15	DJ
North American Morning Briefing : Stock Futures -2-	Mar. 04	DJ
Transcript : Annexon, Inc. - Special Call	Mar. 01
JPMorgan Upgrades Annexon to Overweight From Neutral, Price Target is $11	Mar. 01	MT
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference	Feb. 27	GL
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference	Feb. 27	AQ
ANNEXON REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(4)	Feb. 21	AQ
Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach	Feb. 21	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Annexon, Inc.

Equities

ANNX

US03589W1027

Summary

Filters